$ML
MONEYLION INC.

2023 Q4 Form 10-Q Financial Statement

#000095017023059806 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $113.0M $110.3M $88.75M
YoY Change 18.98% 24.24% 100.7%
Cost Of Revenue $31.52M $32.80M $28.84M
YoY Change 16.76% 13.74% 1477.52%
Gross Profit $81.45M $77.40M $59.91M
YoY Change 19.86% 29.19% 41.33%
Gross Profit Margin 72.1% 70.2% 67.51%
Selling, General & Admin $42.70M $41.40M $45.45M
YoY Change -18.37% -8.9% 9.22%
% of Gross Profit 52.42% 53.49% 75.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.423M $225.0K $319.0K
YoY Change 5.49% -29.47% -34.36%
% of Gross Profit 7.89% 0.29% 0.53%
Operating Expenses $82.70M $109.2M $112.9M
YoY Change -2.7% -3.33% 54.2%
Operating Profit -$1.250M $1.101M -$24.17M
YoY Change -92.67% -104.55% -21.62%
Interest Expense -$6.734M $7.088M $7.880M
YoY Change -17.49% -10.05% 27.26%
% of Operating Profit 643.78%
Other Income/Expense, Net $2.599M $2.358M $460.0K
YoY Change -91.24% 412.61% 235.77%
Pretax Income -$5.385M -$3.710M -$20.96M
YoY Change -95.93% -82.3% -14.94%
Income Tax -$1.190M $400.0K $53.00K
% Of Pretax Income
Net Earnings -$4.195M -$4.110M -$21.02M
YoY Change -96.94% -80.44% -25.38%
Net Earnings / Revenue -3.71% -3.73% -23.68%
Basic Earnings Per Share -$0.40 -$0.09
Diluted Earnings Per Share -$0.41 -$0.40 -$0.09
COMMON SHARES
Basic Shares Outstanding 10.28M 10.17M 242.8M
Diluted Shares Outstanding 10.22M 244.7M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $92.20M $94.30M $126.4M
YoY Change -20.43% -25.38% -57.26%
Cash & Equivalents $92.20M $94.27M $126.4M
Short-Term Investments
Other Short-Term Assets $5.987M $6.000M $4.649M
YoY Change -32.0% 29.06% -54.0%
Inventory
Prepaid Expenses
Receivables $172.8M $158.1M $130.1M
Other Receivables $15.98M $19.10M $20.82M
Total Short-Term Assets $287.0M $277.5M $281.9M
YoY Change -0.63% -1.57% -32.59%
LONG-TERM ASSETS
Property, Plant & Equipment $1.864M $2.111M $2.896M
YoY Change -37.37% -27.11% 392.52%
Goodwill $161.3M
YoY Change
Intangibles $176.5M $180.9M $205.7M
YoY Change -9.12% -12.04%
Long-Term Investments
YoY Change
Other Assets $53.56M $51.03M $62.84M
YoY Change -2.01% -18.79% 1771.91%
Total Long-Term Assets $228.3M $234.8M $476.9M
YoY Change -25.77% -50.77% 846.98%
TOTAL ASSETS
Total Short-Term Assets $287.0M $277.5M $281.9M
Total Long-Term Assets $228.3M $234.8M $476.9M
Total Assets $515.3M $512.3M $758.8M
YoY Change -13.6% -32.49% 61.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $52.40M $45.60M $54.05M
YoY Change -9.86% -15.63% 43.1%
Accrued Expenses $6.989M $7.900M $9.395M
YoY Change -27.33% -15.91% 12.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.39M $53.50M $63.44M
YoY Change -12.34% -15.67% 37.52%
LONG-TERM LIABILITIES
Long-Term Debt $189.8M $194.4M $241.6M
YoY Change -18.21% -19.55% 453.9%
Other Long-Term Liabilities $15.08M $15.87M $51.64M
YoY Change -54.99% -69.27% 125.35%
Total Long-Term Liabilities $15.08M $15.87M $293.3M
YoY Change -54.99% -94.59% 340.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.39M $53.50M $63.44M
Total Long-Term Liabilities $15.08M $15.87M $293.3M
Total Liabilities $258.0M $256.3M $356.7M
YoY Change -20.35% -28.16% 51.01%
SHAREHOLDERS EQUITY
Retained Earnings -$702.7M -$698.5M -$523.0M
YoY Change 6.8% 33.57%
Common Stock $1.000K $1.000K $25.00K
YoY Change -96.15% -96.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.700M $9.700M $9.700M
YoY Change 0.0% 0.0%
Treasury Stock Shares $970.0K
Shareholders Equity $257.2M $256.0M $228.9M
YoY Change
Total Liabilities & Shareholders Equity $515.3M $512.3M $758.8M
YoY Change -13.6% -32.49% 61.93%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$4.195M -$4.110M -$21.02M
YoY Change -96.94% -80.44% -25.38%
Depreciation, Depletion And Amortization $6.423M $225.0K $319.0K
YoY Change 5.49% -29.47% -34.36%
Cash From Operating Activities $42.23M $36.07M -$386.0K
YoY Change 218.56% -9445.08% -94.2%
INVESTING ACTIVITIES
Capital Expenditures $1.806M $1.527M -$3.452M
YoY Change -25.56% -144.24% 1726.46%
Acquisitions
YoY Change
Other Investing Activities -$41.16M -$26.45M -$24.61M
YoY Change 9.72% 7.47% -36.01%
Cash From Investing Activities -$42.97M -$27.98M -$28.06M
YoY Change 7.58% -0.32% -27.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.801M -9.255M 439.0K
YoY Change -34.21% -2208.2% -99.86%
NET CHANGE
Cash From Operating Activities 42.23M 36.07M -386.0K
Cash From Investing Activities -42.97M -27.98M -28.06M
Cash From Financing Activities -5.801M -9.255M 439.0K
Net Change In Cash -6.537M -1.158M -28.01M
YoY Change -81.59% -95.87% -110.48%
FREE CASH FLOW
Cash From Operating Activities $42.23M $36.07M -$386.0K
Capital Expenditures $1.806M $1.527M -$3.452M
Free Cash Flow $40.43M $34.55M $3.066M
YoY Change 273.23% 1026.71% -147.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001807846
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39346
dei Entity Registrant Name
EntityRegistrantName
MoneyLion Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0849243
dei Entity Address Address Line1
EntityAddressAddressLine1
30 West 21st Street
dei Entity Address Address Line2
EntityAddressAddressLine2
9th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10010
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
300-9865
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10281902
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94266000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115864000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4095000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
36235000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
6750000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
37845000
CY2023Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
190152000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
169976000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32073000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24841000
CY2023Q3 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
124924000
CY2022Q4 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
113963000
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
158079000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
145135000
CY2023Q3 ml Enterprise Receivables
EnterpriseReceivables
19109000
CY2022Q4 ml Enterprise Receivables
EnterpriseReceivables
19017000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2111000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2976000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
180911000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
194247000
CY2022Q4 us-gaap Goodwill
Goodwill
26600000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
51030000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54658000
CY2023Q3 us-gaap Assets
Assets
512256000
CY2022Q4 us-gaap Assets
Assets
596342000
CY2023Q3 ml Secured Loans
SecuredLoans
74257000
CY2022Q4 ml Secured Loans
SecuredLoans
88617000
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
45581000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
58129000
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
405000
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
337000
CY2023Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
120163000
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
143394000
CY2023Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
120163000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
143394000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15870000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33496000
CY2023Q3 us-gaap Liabilities
Liabilities
256276000
CY2022Q4 us-gaap Liabilities
Liabilities
323973000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
173208000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
964203000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
766839000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-698524000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-657979000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
32333
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
32333
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
255980000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99161000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
512256000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596342000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
107000000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
86397000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
300978000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
238366000
CY2023Q3 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
3258000
CY2022Q3 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
2351000
ml Interest Income On Loan Net
InterestIncomeOnLoanNet
9490000
ml Interest Income On Loan Net
InterestIncomeOnLoanNet
7436000
CY2023Q3 us-gaap Revenues
Revenues
110258000
CY2022Q3 us-gaap Revenues
Revenues
88748000
us-gaap Revenues
Revenues
310468000
us-gaap Revenues
Revenues
245802000
CY2023Q3 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
25121000
CY2022Q3 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
27428000
ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
67194000
ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
77453000
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
23511000
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
25619000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
70491000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
74160000
CY2023Q3 us-gaap Marketing Expense
MarketingExpense
7029000
CY2022Q3 us-gaap Marketing Expense
MarketingExpense
6954000
us-gaap Marketing Expense
MarketingExpense
19970000
us-gaap Marketing Expense
MarketingExpense
27847000
CY2023Q3 ml Direct Operating Cost
DirectOperatingCost
32813000
CY2022Q3 ml Direct Operating Cost
DirectOperatingCost
28837000
ml Direct Operating Cost
DirectOperatingCost
94845000
ml Direct Operating Cost
DirectOperatingCost
79427000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
4968000
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
7546000
us-gaap Professional Fees
ProfessionalFees
14485000
us-gaap Professional Fees
ProfessionalFees
21486000
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5891000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5327000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
17540000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
15241000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9824000
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-11209000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-30038000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-31820000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
109157000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
112920000
us-gaap Operating Expenses
OperatingExpenses
314563000
us-gaap Operating Expenses
OperatingExpenses
327434000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1101000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24172000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4095000
us-gaap Operating Income Loss
OperatingIncomeLoss
-81632000
CY2023Q3 us-gaap Interest Expense
InterestExpense
7088000
CY2022Q3 us-gaap Interest Expense
InterestExpense
7880000
us-gaap Interest Expense
InterestExpense
21929000
us-gaap Interest Expense
InterestExpense
21638000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
81000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-414000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
68000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7275000
CY2022Q3 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-10214000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6613000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-14034000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2358000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
460000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5264000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-447000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3710000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20964000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40936000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82408000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28348000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-4110000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-21017000
us-gaap Profit Loss
ProfitLoss
-41050000
us-gaap Profit Loss
ProfitLoss
-54060000
CY2022Q3 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-1688000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-4892000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4110000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22705000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40360000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-58952000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.78
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.45
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10221956
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10221956
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8156757
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8156757
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9375221
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9375221
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7910074
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7910074
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
253665000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5702000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
723000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4110000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
255980000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99161000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16657000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-59000
ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
1914000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
304000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
45000
ml Reversal Of Previously Accrued Dividends On Preferred Stock
ReversalOfPreviouslyAccruedDividendsOnPreferredStock
690000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2976000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
174849000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
493000
us-gaap Net Income Loss
NetIncomeLoss
-41050000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
255980000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
220284000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5127000
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
440000
CY2022Q3 ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
5532000
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
20250000
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1688000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-21017000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
228928000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
221684000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13643000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1217000
ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
22250000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8963000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
20250000
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-4892000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-127000
us-gaap Net Income Loss
NetIncomeLoss
-54060000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
228928000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-4110000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-21017000
us-gaap Profit Loss
ProfitLoss
-41050000
us-gaap Profit Loss
ProfitLoss
-54060000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25121000
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27428000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
67194000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
77453000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6106000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6157000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
18403000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15584000
CY2023Q3 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-380000
CY2022Q3 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-700000
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-1778000
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-1405000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
81000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-414000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
68000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7275000
CY2022Q3 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-10214000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6613000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-14034000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
151000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
178000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
209000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-730000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5702000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5127000
us-gaap Share Based Compensation
ShareBasedCompensation
16657000
us-gaap Share Based Compensation
ShareBasedCompensation
13643000
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-17000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-510000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-28442000
CY2023Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
166000
CY2022Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-118000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
404000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-87000
CY2023Q3 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
-2144000
CY2022Q3 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
3308000
ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
278000
ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
4960000
CY2023Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
733000
CY2022Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6084000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3627000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9104000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2771000
CY2022Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2270000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5878000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3113000
CY2023Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1207000
CY2022Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-998000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5422000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3827000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36072000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-386000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74115000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9896000
CY2023Q3 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
26448000
CY2022Q3 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
24612000
ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
79280000
ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
76559000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1527000
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3452000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4202000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6464000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18584000
ml Settlement Of Contingent Consideration Related To Mergers And Acquisitions
SettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
-1116000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27975000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28064000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84598000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101607000
CY2023Q3 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
10000000
CY2022Q3 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
15000000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
24029000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
375000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-24000000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
10000000
ml Borrowings From Secured Lenders
BorrowingsFromSecuredLenders
69300000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
132000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1625000
ml Payments For Automatic Conversion Of Redeemable Convertible Preferred Stock
PaymentsForAutomaticConversionOfRedeemableConvertiblePreferredStock
-3007000
CY2023Q3 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
723000
CY2022Q3 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
440000
ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-59000
ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
1217000
CY2023Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
22000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9255000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
439000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42210000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54488000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1158000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28011000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52693000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57015000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102174000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217220000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153709000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246224000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101016000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189209000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101016000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189209000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
6738000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
7515000
us-gaap Interest Paid Net
InterestPaidNet
21246000
us-gaap Interest Paid Net
InterestPaidNet
19777000
CY2022Q3 ml Voluntary Conversion Of Preferred Stock To Common Stock
VoluntaryConversionOfPreferredStockToCommonStock
20250000
ml Voluntary Conversion Of Preferred Stock To Common Stock
VoluntaryConversionOfPreferredStockToCommonStock
45000
ml Voluntary Conversion Of Preferred Stock To Common Stock
VoluntaryConversionOfPreferredStockToCommonStock
20250000
ml Automatic Conversion Of Redeemable Convertible Preferred Stock To Common Stock
AutomaticConversionOfRedeemableConvertiblePreferredStockToCommonStock
174849000
CY2022Q3 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-1688000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-4892000
ml Issuance Of Common Stock To Settle Accrued Dividends On Preferred Stock And Preferred Stock Equivalents
IssuanceOfCommonStockToSettleAccruedDividendsOnPreferredStockAndPreferredStockEquivalents
3280000
CY2022Q3 ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
-255000
ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
1864000
ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
202355000
CY2022Q3 ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
5532000
ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
1914000
ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
22250000
ml Equity Issued As Settlement Of Contingent Consideration Related To Engine Acquisition
EquityIssuedAsSettlementOfContingentConsiderationRelatedToEngineAcquisition
1440000
CY2022Q3 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
136760000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1068000
ml Contingent Consideration Issued Related To Mergers And Acquisitions
ContingentConsiderationIssuedRelatedToMergersAndAcquisitions
45336000
ml Lease Liabilities Incurred In Exchange For Operating Rightofuse Assets
LeaseLiabilitiesIncurredInExchangeForOperatingRightofuseAssets
7568000
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-30 reverse stock split
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
At the effective time of the Reverse Stock Split, every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock, and the total number of shares of Class A Common Stock authorized for issuance was reduced by a corresponding proportion from 2,000,000,000 shares to 66,666,666 shares.
us-gaap Conversion Of Stock Type Of Stock Converted
ConversionOfStockTypeOfStockConverted
every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock
CY2023Q3 ml Service And Subscription Fees
ServiceAndSubscriptionFees
67841000
CY2022Q3 ml Service And Subscription Fees
ServiceAndSubscriptionFees
52109000
ml Service And Subscription Fees
ServiceAndSubscriptionFees
196547000
ml Service And Subscription Fees
ServiceAndSubscriptionFees
149271000
CY2023Q3 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
3258000
CY2022Q3 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
2351000
ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
9490000
ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
7436000
CY2023Q3 ml Total Consumer Revenues
TotalConsumerRevenues
71099000
CY2022Q3 ml Total Consumer Revenues
TotalConsumerRevenues
54460000
ml Total Consumer Revenues
TotalConsumerRevenues
206037000
ml Total Consumer Revenues
TotalConsumerRevenues
156707000
CY2023Q3 ml Enterprise Service Revenues
EnterpriseServiceRevenues
39159000
CY2022Q3 ml Enterprise Service Revenues
EnterpriseServiceRevenues
34288000
ml Enterprise Service Revenues
EnterpriseServiceRevenues
104431000
ml Enterprise Service Revenues
EnterpriseServiceRevenues
89095000
CY2023Q3 us-gaap Revenues
Revenues
110258000
CY2022Q3 us-gaap Revenues
Revenues
88748000
us-gaap Revenues
Revenues
310468000
us-gaap Revenues
Revenues
245802000
CY2023Q3 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2022Q3 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2023Q3 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2023Q3 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
396000
CY2022Q3 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
568000
ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
1069000
ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
1614000
CY2023Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
73842000
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
73451000
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
97586000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
77688000
CY2023Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
171428000
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
151139000
CY2023Q3 ml Fees Receivables
FeesReceivables
13671000
CY2022Q4 ml Fees Receivables
FeesReceivables
14019000
CY2023Q3 ml Subscription Receivables
SubscriptionReceivables
3487000
CY2022Q4 ml Subscription Receivables
SubscriptionReceivables
3419000
CY2023Q3 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
94000
CY2022Q4 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
331000
CY2023Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
1472000
CY2023Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
190152000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
169976000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4950000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5121000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2839000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2145000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2111000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2976000
CY2023Q3 us-gaap Depreciation
Depreciation
225000
CY2022Q3 us-gaap Depreciation
Depreciation
318000
us-gaap Depreciation
Depreciation
812000
us-gaap Depreciation
Depreciation
805000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
163360000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
136760000
CY2022Q4 us-gaap Goodwill
Goodwill
26600000
ml Goodwill Impaired Impairment Loss
GoodwillImpairedImpairmentLoss
26721000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
ml Goodwill Gross Other Increase Decrease
GoodwillGrossOtherIncreaseDecrease
121000
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
121000
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
163481000
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
163481000
CY2023Q3 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
41556000
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
41495000
CY2023Q3 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1672000
CY2022Q4 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1812000
CY2023Q3 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2022Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2023Q3 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
15960000
CY2022Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
16620000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38777000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26180000
CY2023Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
180911000
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
194247000
CY2023Q3 ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
1454000
CY2022Q3 ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
2281000
ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
4305000
ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
5069000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5881000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5838000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17591000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14778000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1268000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
904000
CY2023Q3 ml Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
768000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9518000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1647000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7871000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5890000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
23546000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
23546000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
23546000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22974000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
79737000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
179239000
CY2023Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
34933000
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
32881000
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
5958000
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
8804000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7158000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9123000
CY2023Q3 ml Others Accrued Assets
OthersAccruedAssets
2981000
CY2022Q4 ml Others Accrued Assets
OthersAccruedAssets
3850000
CY2023Q3 us-gaap Other Assets
OtherAssets
51030000
CY2022Q4 us-gaap Other Assets
OtherAssets
54658000
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.118
CY2023Q3 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Goodwill And Intangible Assets
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceGoodwillAndIntangibleAssets
90917000
CY2022Q4 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Goodwill And Intangible Assets
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceGoodwillAndIntangibleAssets
84952000
ml Exceeds Aggregate Principal Amount Percentage
ExceedsAggregatePrincipalAmountPercentage
0.90
CY2023Q3 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
743000
CY2022Q4 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
1383000
CY2023Q3 us-gaap Secured Debt
SecuredDebt
74257000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
88617000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1837000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2606000
CY2023Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
120163000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
143394000
us-gaap Debt Instrument Description
DebtInstrumentDescription
The interest rate as of September 30, 2023 on the Term A-1 Loans and Term A-2 Loans was 14.75% and 14.25%, respectively.
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1092000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
770000
us-gaap Operating Lease Cost
OperatingLeaseCost
2673000
us-gaap Operating Lease Cost
OperatingLeaseCost
2138000
CY2023Q3 us-gaap Area Of Land
AreaOfLand
12765
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
377000
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
111000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
111000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
823000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3093000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2662000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5900000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1100000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
753300000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
786600000
us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
1200000
ml Current Carryforwards Expiration Term
CurrentCarryforwardsExpirationTerm
If not used, the current carryforwards will expire beginning in 2034.
CY2022Q1 ml Annual Limitation Amount Per Year
AnnualLimitationAmountPerYear
8200000
CY2022Q1 ml Net Unrealized Built In Gains
NetUnrealizedBuiltInGains
330700000
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Company's annual limitation is expected to be increased in the first five years
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
121400000
CY2023Q3 ml Net Operating Losses Subject To Limitation
NetOperatingLossesSubjectToLimitation
3800000
CY2023Q3 ml Net Unrealized Built In Gains
NetUnrealizedBuiltInGains
265200000
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
87800000
CY2023Q3 ml Net Operating Losses Available
NetOperatingLossesAvailable
3100000
CY2023Q3 ml Net Operating Losses Restricted
NetOperatingLossesRestricted
6000000
CY2023Q3 ml Net Operating Losses Generated
NetOperatingLossesGenerated
55000000
CY2023Q3 ml Net Operating Loss Carryforwards Solely Subject To Limitation
NetOperatingLossCarryforwardsSolelySubjectToLimitation
58100000
CY2023Q3 ml Net Operating Losses Restricted
NetOperatingLossesRestricted
6000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Shares of Series A Preferred Stock were convertible into shares of Class A Common Stock on a one-for-thirty basis, subject to customary anti-dilution adjustments.
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5702000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5127000
us-gaap Share Based Compensation
ShareBasedCompensation
16657000
us-gaap Share Based Compensation
ShareBasedCompensation
13643000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-4110000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-21017000
us-gaap Profit Loss
ProfitLoss
-41050000
us-gaap Profit Loss
ProfitLoss
-54060000
CY2022Q3 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-1688000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-4892000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4110000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22705000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40360000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-58952000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10221956
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10221956
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8156757
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8156757
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9375221
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9375221
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7910074
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7910074
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.78
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.45
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3756521
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3756521
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4219063
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4219063
CY2023Q3 ml Cash Paid To Equityholders
CashPaidToEquityholders
14514000
CY2023Q3 ml Shares Exchange
SharesExchange
8883228
CY2023Q3 ml Common Stock Option To Acquire
CommonStockOptionToAcquire
196728
CY2023Q3 ml Common Stock Value Vested Option
CommonStockValueVestedOption
8960000
CY2023Q3 ml Business Combination Purchase Price Value
BusinessCombinationPurchasePriceValue
271096000
us-gaap Repayments Of Debt
RepaymentsOfDebt
5703000
CY2023Q3 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
2868000
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8000000
ml Payment Related To Contingent Consideration To Equity Holders And Advisors
PaymentRelatedToContingentConsiderationToEquityHoldersAndAdvisors
459000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
254901000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-58430000
CY2022Q4 ml Unsettled Restricted Shares Payable
UnsettledRestrictedSharesPayable
2444000
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
-180000
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
15417000

Files In Submission

Name View Source Status
ml-20230930_cal.xml Edgar Link unprocessable
0000950170-23-059806-index-headers.html Edgar Link pending
0000950170-23-059806-index.html Edgar Link pending
0000950170-23-059806.txt Edgar Link pending
0000950170-23-059806-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img203862565_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
ml-20230930.htm Edgar Link pending
ml-20230930.xsd Edgar Link pending
ml-ex10_1.htm Edgar Link pending
ml-ex31_1.htm Edgar Link pending
ml-ex31_2.htm Edgar Link pending
ml-ex32_1.htm Edgar Link pending
ml-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ml-20230930_def.xml Edgar Link unprocessable
ml-20230930_pre.xml Edgar Link unprocessable
ml-20230930_lab.xml Edgar Link unprocessable
ml-20230930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending